v3.26.1
Related Parties
6 Months Ended
Jun. 30, 2026
Related Party Transactions [Abstract]  
Related Parties Related Parties
The Company’s significant transactions with its related parties are primarily comprised of revenue generating activities under collaboration and license agreements.
Significant related party transactions included in the condensed consolidated balance sheet, excluding the Company’s investments and equity method investments, are summarized below (in thousands):
As of June 30, 2026As of December 31, 2025
Deferred revenue, current and non-current:
Allonnia$36,495 $36,495 
Arcaea28,413 28,413 
$64,908 $64,908 
Significant related party transactions included in the condensed consolidated statements of operations and comprehensive loss, excluding the losses on the Company’s investments and equity method investments, are summarized below (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
20252025
Revenue:
Genomatica$78 $352 
Ayana Bio342 582 
Allonnia— 
BiomEdit— 7,583 
$420 $8,518 
During the three and six months ended June 30, 2026, the Company recognized zero revenue from related parties.
Refer to Note 6 for additional details on the Company’s investments and equity method investments held in its related parties.